Adaptive Clinical Trials: Ethical, Regulatory & Statistical Considerations Symposium

Friday, May 31, 2013 at 1:00pm to 5:00pm

Adaptive Clinical Trials: Ethical, Regulatory & Statistical Considerations Symposium

How can investigators, statisticians, sponsors, and IRBs ensure that they are able to address the scientific, medical, and ethical questions the trials intend to answer with a more rapidly changing design? The Adaptive Clinical Trials: Ethical, Regulatory & Statistical Considerations Symposium, sponsored by Harvard Catalyst, will attempt to provide a general overview of adaptive clinical trials, focusing on ethical, regulatory and statistical considerations of adaptive clinical trial design.

Keynote speaker Donald A. Berry, Ph.D., professor of biostatistics at The University of Texas, MD Anderson Cancer Center, will begin the symposium. Additional speakers and panelists will discuss the ethical, regulatory, and statistical considerations of adaptive clinical trial design. An interactive discussion of a case study will examine the practical considerations encountered when implementing adaptive design methods.

When: May 31, 2013 from 1:00-5:00pm
Registration begins at 12:30pm

Where: Boston Children’s Hospital
Enders Research Building – Folkman Auditorium
300 Longwood Avenue
Boston, MA 02115

Space is limited. Please register, and contact us if you have questions.

Share
Subscribe
Website

https://hms.qualtrics.com/SE/?SID=SV_...

Event Contact Email

helena_han@hms.harvard.edu

Recent Activity

People Going

Getting Here

Event Registration Required

This event requires registration.


NCI CCC